Case Reports of Neuroleptic Malignant Syndrome in Context of Quetiapine Use
- 18 May 2013
- journal article
- research article
- Published by Springer Nature in Psychiatric Quarterly
- Vol. 84 (4) , 523-541
Abstract
A retrospective analysis was followed on 20 case reports covering the possible correlation between the atypical antipsychotic, quetiapine, and neuroleptic malignant syndrome (NMS), determined by the study of 7 different NMS criteria guidelines. A great majority (19) of the case studies did not meet the requirements of all 7 guidelines, frequently due to unreported information. Nor was quetiapine proven to be the sole cause of the possible NMS in the two age groups investigated. Only one case was found to have no other medication or medical conditions confounding the relationship of quetiapine and NMS symptoms, and that case was in the context of a significant quetiapine overdose. The other 19 cases demonstrated the difficulty of identifying the cause of NMS when polypharmacy and other medical conditions are involved. The authors note the need for caution in deciding both the presence of NMS and the causal factors of the symptoms.Keywords
This publication has 128 references indexed in Scilit:
- A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosisJournal of Psychopharmacology, 2010
- Serotonin syndrome induced by augmentation of SSRI with methylphenidatePsychiatry and Clinical Neurosciences, 2008
- Neuroleptic malignant syndrome due to three atypical antipsychotics in a childJournal of Psychopharmacology, 2005
- Serotonin Syndrome With Tramadol and CitalopramAmerican Journal of Psychiatry, 2004
- Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiologyJournal of Neural Transmission, 2002
- OlanzapineDrugs, 2001
- Proposed research diagnostic criteria for neuroleptic malignant syndromeInternational Journal of Neuropsychopharmacology, 1999
- Serotonin Syndrome Associated With Nefazodone and ParoxetineAnnals of Emergency Medicine, 1997
- MRI white matter hyperintensity in neuroleptic malignant syndrome (NMS)?a clue to pathogenesis?Journal of Neural Transmission, 1992
- Neuroleptic Malignant SyndromeClinical Neuropharmacology, 1984